
How are multidisciplinary tumor boards optimizing liver transplantation pathways for HCC patients by leveraging collaboration and emerging biomarkers to improve outcomes?
In the latest episode of the 2026 HCC Creator Weekend™, Dr. Ari Cohen and Dr. Neil Mehta join Dr. Kavi Krishnasamy to map out strategies for effective multidisciplinary care and selection of treatment, from Y90 to liver transplantation, for HCC.
🎧 Tune in on the BackTable app: na2.hubs.ly/H05sZ440
This podcast is supported by Boston Scientific and Sirtex.
#VI644 #InterventionalRadiology #LiverCancer #Y90 #Hepatology #HCC #IRad #FOAMed #MedEd
English





